Common vein pill may cut Post-Surgery fluid swelling in breast cancer patients

NCT ID NCT07588828

Completed Symptom relief Sponsor: Ittefaq Hospital trust Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether Daflon, a medication usually used for vein problems, can reduce seroma — a common fluid buildup after breast cancer surgery. 190 patients took Daflon or a placebo for four weeks after surgery. The goal was to see if it lowers the chance of seroma forming.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Daflon (diosmin and hesperidin)
What this could lead to: If it works, this could offer a simple way to reduce painful fluid buildup after breast cancer surgery, speeding recovery.
What could go wrong: This is a small, single-center Phase 4 trial. The effect may be modest or not apply to all surgery types. Side effects from Daflon are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER SURGERY POST-OPERATIVE SEROMA FORMATION

Contacts and locations

Show contact details

Locations

Ittefaq Hospital Trust

Lahore, Punjab Province, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.